Genocea Biosciences Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Public

  • Employees
  • 74

Employees

  • Stock Symbol
  • GNCAQ

Stock Symbol

Genocea Biosciences General Information

Description

Genocea Biosciences Inc is a USA-based biopharmaceutical company discovering and developing novel cancer immunotherapies using its proprietary ATLAS platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by next-generation sequencing of that patient's tumor. ATLAS zeroes in on both antigens that activate anti-tumor T cell responses and inhibitory antigens, or Inhibigens , that drive pro-tumor immune responses.

Contact Information

Website
www.genocea.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Acorn Park Drive
  • Cambridge, MA 02140
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
OTCM
Vertical(s)
Corporate Office
  • 100 Acorn Park Drive
  • Cambridge, MA 02140
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genocea Biosciences Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
480.00

Genocea Biosciences Financials Summary

As of 31-Mar-2022, Genocea Biosciences has a trailing 12-month revenue of $1.91M.

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 53,454 36,581 62,096 28,116
Revenue 1,911 1,641 1,359 0
EBITDA (34,542) (30,518) (41,196) (36,907)
Net Income (37,191) (33,196) (43,714) (38,950)
Total Assets 38,788 55,967 98,493 52,611
Total Debt 15,485 17,185 23,874 19,919
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Genocea Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Genocea Biosciences‘s full profile, request access.

Request a free trial

Genocea Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Genocea Biosciences‘s full profile, request access.

Request a free trial

Genocea Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Genocea Biosciences Inc is a USA-based biopharmaceutical company discovering and developing novel cancer immunotherapies
Drug Discovery
Cambridge, MA
74 As of 2021

Santa Monica, CA
 

Abingdon, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genocea Biosciences Competitors (88)

One of Genocea Biosciences’s 88 competitors is Kite Pharma, a Formerly VC-backed company based in Santa Monica, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kite Pharma Formerly VC-backed Santa Monica, CA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Cogent Biosciences Formerly VC-backed Waltham, MA
RAPT Therapeutics Formerly VC-backed South San Francisco, CA
Selecta Biosciences Formerly VC-backed Watertown, MA
You’re viewing 5 of 88 competitors. Get the full list »

Genocea Biosciences Patents

Genocea Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022056491-A1 Treatment methods Inactive 14-Sep-2020
US-20210338725-A1 Treatment methods Inactive 02-Apr-2020
WO-2021203022-A1 Treatment methods Inactive 02-Apr-2020
WO-2021203022-A4 Treatment methods Inactive 02-Apr-2020
WO-2020232408-A1 Treatment methods Inactive 15-May-2019 G01N33/5047
To view Genocea Biosciences’s complete patent history, request access »

Genocea Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genocea Biosciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Genocea Biosciences‘s full profile, request access.

Request a free trial

Genocea Biosciences ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Genocea Biosciences’s complete esg history, request access »

Genocea Biosciences FAQs

  • When was Genocea Biosciences founded?

    Genocea Biosciences was founded in 2006.

  • Where is Genocea Biosciences headquartered?

    Genocea Biosciences is headquartered in Cambridge, MA.

  • What is the size of Genocea Biosciences?

    Genocea Biosciences has 74 total employees.

  • What industry is Genocea Biosciences in?

    Genocea Biosciences’s primary industry is Drug Discovery.

  • Is Genocea Biosciences a private or public company?

    Genocea Biosciences is a Public company.

  • What is Genocea Biosciences’s stock symbol?

    The ticker symbol for Genocea Biosciences is GNCAQ.

  • What is Genocea Biosciences’s current revenue?

    The trailing twelve month revenue for Genocea Biosciences is $1.91M.

  • Who are Genocea Biosciences’s competitors?

    Kite Pharma, Adaptimmune Therapeutics, Cogent Biosciences, RAPT Therapeutics, and Selecta Biosciences are some of the 88 competitors of Genocea Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process